Maine BioTek, Inc.

Basic Information

259 MAIN STREET
Suite 208
WINTERPORT, ME, 04496 0408

Company Profile

n/a

Additional Details

Field Value
DUNS: 121149640
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 3


  1. SBIR Phase II: Atlantic Cod Nodavirus Vaccine

    Amount: $499,393.00

    This Small Business Innovation Research (SBIR) Phase II project of develops a recombinant vaccine for the prevention of nodavirus disease of cultured Atlantic cod, fisheries of growing importanct to N ...

    SBIR Phase II 2007 National Science Foundation
  2. A Multivalent Bacterial Vaccine for Atlantic Cod

    Amount: $95,000.00

    The goal of this project (Phase I ¿ III) is to develop a vaccine for the control of diseases in Atlantic cod caused by L. anguillarum and A. salmonicida. To accomplish this we have established the f ...

    SBIR Phase I 2006 Department of Commerce
  3. SBIR Phase I: Atlantic Cod Nodavirus Vaccine

    Amount: $99,929.00

    This Small Business Innovation Research (SBIR) Phase I project will develop a novel recombinant vaccine for the control of viral nervous necrosis (VNN) of cultured Atlantic cod (Gadus morhua) in New ...

    SBIR Phase I 2006 National Science Foundation
  4. Potency, Efficacy and Standardization of a Whole Killed IHN Virus Vaccine

    Amount: $296,000.00

    The salmon and to a lesser extent the trout aquaculture industries in North America consider infectious hematopoietic necrosis virus a major threat to the current and future economic viability and sus ...

    SBIR Phase II 2005 Department of Agriculture
  5. Recombinant ISA Virus Vaccine

    Amount: $296,000.00

    Infectious salmon anemia (ISA) virus is an emerging pathogen of farmed Atlantic salmon (Salmo salar). The virus is among the fish pathogens listed in the Aquatic Animal Health Code of the Office Inter ...

    SBIR Phase II 2004 Department of Agriculture
  6. Preparation of an IHN Virus Whole Killed Vaccine: Retention of Neutralizing Epitope Integrity of the IHN Virus Glycoprotein During Viral...

    Amount: $75,000.00

    NON-TECHNICAL SUMMARY: IHN disease in farmed salmon and trout exerts a negative impact on the productivity and profitability of the aquaculture industry. The purpose of this project is to produce an e ...

    SBIR Phase I 2003 Department of Agriculture
  7. Recombinant ISA Virus Vaccine

    Amount: $75,000.00

    NON-TECHNICAL SUMMARY: ISA virus, an unclassified Orthomyxoviridae is an emerging pathogen associated with disease in farmed Atlantic salmon. Losses incurred in Maine due to ISA alone in 2002 are esti ...

    SBIR Phase I 2003 Department of Agriculture
  8. SBIR Phase I: Recombinant Infectious Hematopoietic Necrosis (IHN) Virus G Protein Vaccine

    Amount: $94,376.00

    This Small Business Innovation Research Phase I project is to develop a vaccine for the control of infectious hematopoietic necrosis (IHN) disease of salmon and trout. An efficacious, safe and reason ...

    SBIR Phase I 2003 National Science Foundation

Agency Micro-sites

US Flag An Official Website of the United States Government